News
Now, nivolumab -- in combination with chemotherapy -- is indicated for the first-line treatment of adults with unresectable ...
Atezolizumab may improve upon perioperative treatment with trastuzumab and chemotherapy in HER2+, locally advanced, resectable gastric or GEJ cancer, researchers say.
10h
GlobalData on MSNDaiichi announces first subject dosing in Enhertu trial for endometrial cancerThe study will be carried out in partnership with The GOG Foundation and the European Network of Gynecological Oncological ...
Let’s get straight to the point: a good nurse can change your experience with cancer and cancer treatment.
6d
SurvivorNet on MSNAn Exciting Option For Difficult-To-Treat HER2+ Gastric Cancer: What New Data Means For PatientsFor the first time, a medicine aimed directly at the HER2 protein improved overall survival after gastric cancer progressed ...
In this small prospective cohort of 7 patients with resistant AOC, 3 achieved complete remission when adding trastuzumab to conventional chemotherapy, suggesting that trastuzumab combined with ...
Mwende was diagnosed with stage 0 breast cancer during a routine check-up. She had no family history, no warning signs. She ...
New first-line therapy for HER2-positive metastatic breast cancer shows promising results in clinical trial data.
Experts explore the evolving landscape of ovarian cancer treatment, emphasizing the need for targeted therapies and biomarker ...
In the DESTINY-Breast09 study, Enhertu (fam-trastuzumab deruxtecan-nxki) plus pertuzumab reduced the risk of disease ...
The following is a summary of "Advances and challenges in targeted therapies for HER2-amplified colorectal cancer," published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results